International Journal of Nanomedicine · 2012 · 90 citations · 36 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryPharmacokinetics Of Anticancer AgentsTargeted Drug DeliveryCancer Drug DeliveryCellular Drug UptakeDrug EncapsulationLiposomal FormulationsLiposome-based DeliveryPharmacokinetics Of Anticancer DrugsAnticancer Drug LoadingEncapsulation EfficiencyLiposomal Delivery SystemsLiposome Delivery SystemsLiposome Drug DeliveryLiposome-drug ConjugatesLiposomesNanocarrier Encapsulation Efficiency
BACKGROUND: Integrins α(v)β(3) and α(v)β(5), both of which specifically recognize the Arg-Gly-Asp (RGD) motif, are overexpressed on many solid tumors and in tumor neovasculature. Thus, coupling the RGD motif to the liposomal surface for achieving active targeting can be a promising strategy for the treatment of tumors. METHODS: Cyclo(Arg-Gly-Asp-D-Phe-Cys) (cRGD) was covalently coupled with the liposomal membrane surface, followed by coating with poly(ethylene glycol) (PEG) using the post-insertion technique. The coupling efficiency of cRGD was determined. Doxorubicin as a model anticancer drug was loaded into liposomes using an ammonium sulfate gradient method to investigate the encapsulation efficiency, cellular uptake by the integrin-overexpressing human glioma cell line U87MG in vitro, and pharmacokinetic properties in Sprague-Dawley rats. RESULTS: cRGD was conjugated to the liposomal surface by a thiol-maleimide coupling reaction. The coupling efficiency reached 98%. The encapsulation efficiency of doxorubicin in liposomes was more than 98%. The flow cytometry test result showed that cRGD-modified liposomes (RGD-DXRL-PEG) had higher cell uptake by U87MG cells, compared with nontargeted liposomes (DXRL-PEG). The cellular uptake was significantly inhibited in the presence of excess free cRGD. Both the targeted (t(1/2) = 24.10 hours) and non-targeted (t(1/2) = 25.32 hours) liposomes showed long circulating properties in rat plasma. The area under the curve of the targeted and nontargeted liposomes was 6.4-fold and 8.3-fold higher than that of doxorubicin solution, respectively. CONCLUSION: This study indicates preferential targeting and long circulating properties for cRGD-modified liposomes in vivo, which could be used as a potential targeted liposomal drug delivery system to treat human glioma.
36
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Si‐Shen Feng · Nanomedicine · 2006 · 1.9K citations · Full text
Structural Basis of Collagen Recognition by Integrin α2β1
Jonas Emsley, Christopher G. Knight, Richard W. Farndale et al. · Cell · 2000 · 994 citations · Full text